Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma

Abstract Background Post-surgical prognosis is usually poor for combined hepatocellular cholangiocarcinoma (CHCC-CC), a rare primary liver cancer. Although midkine (MK) is a prognostic biomarker for several known cancers, it is not known whether it can be used as such in resectable CHCC-CC. This stu...

Full description

Bibliographic Details
Main Authors: Ming-Chun Ma, Yi-Ju Chen, Tai-Jan Chiu, Jui Lan, Chien-Ting Liu, Yi-Ching Chen, Hsin-Ho Tien, Yen-Yang Chen
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Cancer
Subjects:
Combined hepatocellular cholangiocarcinoma (CHCC-CC)
Midkine (MK)
Early recurrence
Prognosis
Online Access:http://link.springer.com/article/10.1186/s12885-018-4146-7

Internet

http://link.springer.com/article/10.1186/s12885-018-4146-7

Similar Items